683 Capital Management, LLC Cue Biopharma, Inc. Transaction History

683 Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $8.08 Million - $13.3 Million	-743,772 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.06 - $15.3 $397,893 - $605,145	39,552 Added 5.62%	743,772 $10.8 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $4 Million - $5.33 Million	366,792 Added 108.7%	704,220 $8.2 Million
Q1 2021 May 17, 2021	BUY	$11.2 - $16.09 $195,193 - $280,416	17,428 Added 5.45%	337,428 $4.12 Million
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $141,200 - $349,400	20,000 Added 6.67%	320,000 $5.08 Million

Q3 2019 Nov 14, 2019	BUY	$6.78 - $9.28 $2.03 Million - $2.78 Million	300,000 New	300,000 $2.53 Million

18.4M

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $22.3M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.